This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Meridian Bioscience Inc (VIVO)

NASDAQ: Health Care

Company Balance Sheet
Sep 2014 Sep 2013 Sep 2012 Sep 2011
Assets
Cash and Equivalents 43.05M 44.28M 31.59M 23.63M
Receivables 23.23M 26.18M 24.18M 24.84M
Inventories 35.50M 34.84M 31.68M 32.69M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 112.75M 114.09M 96.59M 90.35M
Property, Plant & Equipment, Gross 71.16M 67.09M 63.22M 60.51M
Accumulated Depreciation & Depletion 43.55M 41.00M 37.07M 33.97M
Property, Plant & Equipment, Net 27.61M 26.09M 26.16M 26.54M
Intangibles 7.81M 8.06M 10.26M 10.95M
Other Non-Current Assets 4.08M 4.57M 1.27M 4.53M
Total Non-Current Assets 64.18M 62.66M 64.79M 65.14M
Liabilities & Shareholder Equity
Total Assets 176.93M 176.75M 161.38M 155.49M
Accounts Payable 4.97M 5.59M 5.79M 5.55M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 859.00K 979.00K 1.59M 789.00K
Total Current Liabilities 13.74M 21.70M 18.46M 15.26M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 171.00K 1.70M
Other Non-Current Liabilities 2.16M 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 2.16M 0.00 171.00K 1.70M
Total Liabilities 15.90M 21.70M 18.63M 16.97M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 161.03M 155.04M 142.75M 138.52M
Common Par 0.00 0.00 0.00 0.00
Additional Paid In Capital 111.85M 107.41M 102.44M 100.01M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 48.87M 46.89M 40.21M 38.06M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 309.00K 745.00K 95.00K 449.00K
Total Capitalization 161.03M 155.04M 142.75M 138.52M
Total Equity 161.03M 155.04M 142.75M 138.52M
Total Liabilities & Stock Equity 176.93M 176.75M 161.38M 155.49M
Total Common Shares Outstanding 41.62M 41.52M 41.28M 41.24M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 41.46M 41.23M 41.08M 40.72M
Diluted Weighted Shares Outstanding 41.91M 41.90M 41.61M 41.36M
Number of Employees 550 550 510 525
Number of Part-Time Employees 0 0 0 0
VIVO News

VIVO Meridian Bioscience Inc

Analysts Ratings for VIVO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 1 1
Moderate Buy 1 1 1 1
Hold 4 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
GET VIVO ANALYST REPORT

Brokerage Partners

VIVO Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs